Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



REGENERON PHARMACEUTICALS, INC. Hits 29.73% Profit Target as Forecasted by QuantWave

May 30, 2025
REGENERON PHARMACEUTICALS, INC. (NASDAQ: REGN) achieved a significant milestone as it hit the price target forecasted by QuantWave, providing investors with a profit of 29.73%. The forecast signal was issued on February 28, 2025, with a price of $697.71 and a predicted direction of short. On May 30, 2025, the stock reached the target price of $490.28, confirming the accuracy of QuantWave's analytics.

This success highlights the effectiveness of QuantWave's automated forecasting platform in predicting stock movements. The achievement of the price target for REGENERON PHARMACEUTICALS, INC. demonstrates the valuable insights provided by QuantWave to investors, enabling them to make informed decisions and generate profits in the market.

In the broader context of QuantWave's analytics, this forecast success reaffirms the platform's capabilities in offering accurate predictions for a wide range of stocks. Investors can leverage QuantWave to access forecasting signals and opportunities for potential profits in the stock market.

For those interested in exploring the investment strategy behind QuantWave further, QuantSchool offers educational resources on the professional investment framework utilized by the platform. QuantSchool provides insights into the key principles for generating consistent income using the QuantWave forecasting system, empowering investors to make informed investment decisions.
If you want to leave a comment, then you need Login or Register





Other data for REGN

Related data

REGNJuly 5, 2025Regeneron Pharmaceuticals: Revolutionizing Healthcare with Innovative Drug Approvals  ~1 min.

Regeneron Pharmaceuticals, Inc. recently made headlines with the approval of Dupixent by the US FDA, in collaboration with Sanofi....


REGNJune 27, 2025Regeneron Pharmaceuticals Inc. Continues to Impress Investors as UBS Lowers Price Target  ~1 min.

Regeneron Pharmaceuticals Inc. has been making waves in the biotech industry, with impressive financial and operating results....


REGNJune 5, 2025REGENERON PHARMACEUTICALS, INC. Hits Price Target Forecast with 33.76% Profit Margin  ~1 min.

QuantWave's forecast signal for REGENERON PHARMACEUTICALS, INC. on December 13, 2024, predicted a short direction with a price of 728.18 $. On June 5, 2025, the stock reached the target price of 482....


REGNJune 5, 2025REGENERON PHARMACEUTICALS, INC. Hits Forecast Price Target with a 32.0% Profit  ~1 min.

REGENERON PHARMACEUTICALS, INC. has successfully reached the forecast price target set by QuantWave, resulting in a profit of 32.0%. The forecast signal was issued on December 31, 2024, with a price of $709....


REGNJune 4, 2025REGENERON PHARMACEUTICALS, INC. Hits QuantWave Price Target Forecast with 27.18% Profit  ~2 min.

REGENERON PHARMACEUTICALS, INC. (REGN) has successfully reached the price target forecast set by QuantWave, resulting in a profit of 27.18%....


REGNJune 4, 2025REGENERON PHARMACEUTICALS, INC. Hits Price Target Forecast with Profit of 26.25%  ~1 min.

REGENERON PHARMACEUTICALS, INC. stock recently achieved the price target forecast set by QuantWave on March 21, 2025. The forecast indicated a short direction, with the stock price at $657....


REGNJune 4, 2025REGENERON PHARMACEUTICALS, INC. Hits Price Target Forecast with 26.25% Profit: QuantWave's Success in Stock Prediction  ~2 min.

REGENERON PHARMACEUTICALS, INC. has recently reached the price target forecast set by QuantWave on June 4, 2025....


REGNJune 4, 2025REGENERON PHARMACEUTICALS, INC. Hits QuantWave Price Target Forecast with 27.18% Profit  ~1 min.

REGENERON PHARMACEUTICALS, INC. (ticker: REGN) has successfully achieved the price target forecast set by QuantWave, realizing a profit of 27.18%....


REGNMay 30, 2025REGENERON PHARMACEUTICALS, INC. Hits QuantWave's Price Target with 20.42% Profit  ~2 min.

In a recent success story for QuantWave, the automated forecasting platform accurately predicted a short position for REGENERON PHARMACEUTICALS, INC....


REGNMay 30, 2025REGENERON PHARMACEUTICALS, INC. Stock Hits Price Target Forecast, Bringing 27.31% Profit  ~1 min.

On March 4, 2025, QuantWave, the automated forecasting platform, issued a short signal for REGENERON PHARMACEUTICALS, INC. stock when it was trading at $674.49....


REGNApril 4, 2025REGENERON PHARMACEUTICALS, INC. Hits Price Target Forecast with 16.52% Profit  ~1 min.

QuantWave, an automated forecasting platform, successfully predicted the short movement for REGENERON PHARMACEUTICALS, INC. with a price target of 572.6 $ on 2025-04-04, achieving a profit of 16.52%....


REGNAugust 13, 2024REGENERON PHARMACEUTICALS, INC. Hits 19.03% Profit Target as Forecasted by QuantWave  ~1 min.

On May 28, 2024, QuantWave's automated forecasting platform issued a long signal for REGENERON PHARMACEUTICALS, INC., with a price target of 1153.39 $....


REGNMay 30, 2025REGENERON PHARMACEUTICALS, INC. Hits Price Target Forecast with 27.31% Profit  ~1 min.

REGENERON PHARMACEUTICALS, INC. stock recently achieved the price target forecast set by QuantWave, resulting in a profit of 27.31%....


REGNApril 4, 2025REGENERON PHARMACEUTICALS, INC. Hits Price Target Forecast with 16.52% Profit  ~2 min.

REGENERON PHARMACEUTICALS, INC. stock has successfully reached the price target forecast set by QuantWave on April 4, 2025....


REGNApril 4, 2025REGENERON PHARMACEUTICALS, INC. Hits Price Target Forecast with 16.89% Profit  ~1 min.

QuantWave's forecast for REGENERON PHARMACEUTICALS, INC. proved accurate as the stock reached the predicted target price on April 4, 2025....